查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物信息學服務行業分析、規模、份額、增長、趨勢和預測 2023-2030 年的全球市場研究報告
市場調查報告書
商品編碼
1264202

生物信息學服務行業分析、規模、份額、增長、趨勢和預測 2023-2030 年的全球市場研究報告

Global Bioinformatics Service Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

生物信息學服務在為科學研究的各個領域提供重要支持方面始終具有巨大的潛力。 生物信息學是對生物數據的研究以及開發方法和軟件工具以更好地理解它的學科。 生物信息學用於生物學應用，例如基因組學、藥物開發、結構生物學研究和生物醫學成像。 生物信息學還用於組織和搜索數據，並藉助現代分析工具評估眾多實驗元素。

市場動態：

由於技術進步、信息技術在醫學中的日益普及以及生命科學和生物技術研究領域對數據管理工具的需求不斷增長，在過去十年中，全球生物信息學服務市場發展迅速。 此外，生物技術、藥物發現和生物製藥領域研發活動的增加是對市場增長產生重大影響的一個因素。 此外，越來越多的政府舉措也有助於生物技術市場的全球擴張。 此外，食品、生物修復、農業、計量學和採購行業的許多組織都在使用生物信息學管理來提高產品質量和商店網絡。 生物信息學服務，如數據融合、控制、先導披露和心理測試，越來越多地接受各種規模的公司改進的信息披露。 擴大此類生物信息學服務的應用領域對於為市場進入者創造新的收入來源、支持這些服務的選擇以及促進整個市場的增長至關重要。 另一方面，高昂的服務成本和缺乏經驗豐富的生物信息學專業人員可能會阻礙行業的擴張。

這份研究報告涵蓋了波特的五力模型、市場吸引力分析、價值鏈分析等。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外，這些工具還能夠全面評估全球生物信息學服務市場的各個細分市場。 生物信息學服務行業的發展和趨勢為這項研究提供了一個整體方法。

市場細分：

生物信息學服務的市場細分按國家和地區提供詳細的細分數據，以幫助確定每種產品和服務的目標受眾和未來商機。

按產品類型

  • 藥物開發
  • 基因療法
  • 分子醫學
  • 獸醫學
  • 其他

由最終用戶/應用程序

  • 學術和研究中心
  • 製藥和生物技術行業
  • 法醫實驗室
  • 其他

按地區分析：

本部分介紹了區域前景，重點關注北美、歐洲、亞太地區、拉丁美洲、中東和非洲的生物信息學服務市場當前和未來的需求。 此外，我們還關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 生物信息學服務市場的主要參與者是 Illumina、Thermo Fisher Scientific、Strand Life Sciences、CD Genomics、Biomax Informatics、DNANEXUS、Agilent Technologies、QIAGEN、Gene Codes、BGI Group、Gene Code、PerkinElmer、Premier Biosoft、Biomatters Geneious、Creative - Biolabs、DNASTAR、GSL Biotech LLC (SnapGene)、FIOS Genomics。 本節全面介紹了競爭格局，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。

如果您有任何定制要求，請寫信給我們。 我們的研究團隊可以根據您的需要提供定制報告。

內容

第一章前言

  • 報告內容
    • 目的
    • 目標受眾
    • USP（獨特的銷售建議）及其提供的內容
  • 調查範圍
  • 調查方法
    • 市場調研流程
    • 市場研究方法

第 2 章執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章生物信息學服務 - 行業分析

  • 簡介 - 市場動態
  • 市場驅動因素
  • 市場製約因素
  • 機會
  • 行業趨勢
  • 波特的五力分析
  • 市場吸引力分析
    • 按產品類型
    • 最終用戶
    • 按地區

第四章價值鏈分析

  • 價值鏈分析
  • 原材料分析
    • 原材料清單
    • 原材料製造商列表
    • 主要原材料價格走勢
  • 潛在買家名單
  • 營銷渠道
    • 直接營銷
    • 間接營銷
    • 市場發展趨勢

第 5 章 COVID-19 爆發的影響分析

第 6 章生物信息學服務的全球市場分析：按產品類型

  • 摘要：按產品類型
  • 過去和未來的數據
  • 分析：按產品類型
  • 藥物開發市場：按地區細分
  • 基因治療市場：按地區
  • 分子醫學市場：按地區
  • 獸藥市場：按地區
  • 其他市場：按地區

第 7 章生物信息學服務的全球市場分析：最終用戶

  • 最終用戶總結
  • 過去和未來的數據
  • 最終用戶分析
  • 學術和研究中心市場：按調查
  • 製藥和生物技術行業市場：按地區劃分
  • 法醫實驗室市場：按地區
  • 其他市場：按地區

第 8 章生物信息學服務的全球市場分析：按地區

  • 區域展望
  • 介紹
  • 北美
    • 摘要、實際數據、預測數據
    • 按北美細分
    • 北美：按國家/地區列出
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 摘要、實際數據、預測數據
    • 歐洲（按細分市場）
    • 歐洲：按國家/地區分類
    • 英國
    • 法國
    • 德國
    • 意大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 摘要、實際數據、預測數據
    • 按亞太地區細分
    • 亞太地區：國家/地區信息
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 拉丁美洲
    • 摘要、實際數據、預測數據
    • 拉丁美洲細分市場
    • 拉丁美洲：按國家/地區列出
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲地區
  • 中東和非洲
    • 摘要、實際數據、預測數據
    • 中東和非洲分部信息
    • 中東和非洲：按國家/地區列出
    • 沙特阿拉伯
    • 阿聯酋
    • 以色列
    • 南非
    • 其他中東和非洲地區

第9章生物信息服務企業競爭格局

  • 生物信息學服務市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他擴展

第十章公司簡介

  • 公司股票分析
  • 市場集中度
  • 因美納
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 賽默飛世爾科技
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 斯特蘭德生命科學
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • CD 基因組學
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 百瑪信息學
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • DNA 聯繫
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 安捷倫科技
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 凱傑
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 基因密碼
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 華大基因集團
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 基因密碼
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 珀金埃爾默
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • Premier Biosoft
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • 生物物質基因組
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • Creative-Biolabs
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • DNA之星
    • 公司概況
    • 產品介紹
    • 近期趨勢
  • GSL 生物技術有限責任公司 (SnapGene)
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • FIOS 基因組學
    • 公司概況
    • 產品介紹
    • 近期趨勢

注意：在公司簡介、財務細節、近期發展等方面，基於可用信息，私人控股公司可能不包括在內。

Product Code: VMR11217038

When it comes to offering critical support to various fields of scientific study, bioinformatics services have always had enormous potential. Bioinformatics is the study of biological data and the development of methods and software tools to understand it better. Bioinformatics is utilized in biological applications, including genomics, drug development, structural biology research, and biomedical imaging. Bioinformatics is also used to organize and retrieve data and evaluate numerous experimental elements with the help of contemporary analytical tools.

Market Dynamics:

The global bioinformatics services market has proliferated over the last decade due to technological advancements, increased information technology use in health care, and increased demand for data management tools in the life sciences and biotechnology research sectors. Additionally, increased research and development activities in biotechnology, drug discovery, and biopharmaceuticals are significant drivers impacting the market's growth. Furthermore, increased government initiatives contribute to the global expansion of the biotechnology market. Moreover, many organizations, such as those in the food, bioremediation, farming, measurement, and buyer industries, are using bioinformatics administrations to improve the quality of their products and store network measures. Bioinformatics services such as data fusion, control, lead disclosure, information the board, in silico examination, and businesses of all sizes are increasingly adopting improved information disclosure. This expansion of bioinformatics services' application sectors is essential to create new revenue streams for market participants, which will support the selection of these services and lead to overall market growth. The high cost of services and scarcity of experienced bioinformatics professionals, on the other hand, may hinder industry expansion.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bioinformatics service. The growth and trends of bioinformatics service industry provide a holistic approach to this study.

Market Segmentation:

This section of the bioinformatics service market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Drug Development
  • Gene Therapy
  • Molecular Medicine
  • Veterinary Science
  • Others

By End Users/Applications

  • Academics And Research Centers
  • Pharmaceutical And Biotechnology Industries
  • Forensics Laboratories
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Bioinformatics Service market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the bioinformatics service market include Illumina, Thermo Fisher Scientific, Strand Life Sciences, CD Genomics, Biomax Informatics, DNANEXUS, Agilent Technologies, QIAGEN, Gene Codes, BGI Group, Gene Code, PerkinElmer, Premier Biosoft, Biomatters Geneious, Creative-Biolabs, DNASTAR, GSL Biotech LLC (SnapGene), FIOS Genomics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BIOINFORMATICS SERVICE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product Type
    • 3.7.2 By End Users
    • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BIOINFORMATICS SERVICE MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Drug Development Market by Regions
  • 6.6 Gene Therapy Market by Regions
  • 6.5 Molecular Medicine Market by Regions
  • 6.7 Veterinary Science Market by Regions
  • 6.8 Others Market by Regions

7 . GLOBAL BIOINFORMATICS SERVICE MARKET ANALYSIS BY END USERS

  • 7.1 Overview by End Users
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End Users
  • 7.4 Academics and Research Centers Market by Regions
  • 7.5 Pharmaceutical and Biotechnology Industries Market by Regions
  • 7.6 Forensics Laboratories Market by Regions
  • 7.7 Others Market by Regions

8 . GLOBAL BIOINFORMATICS SERVICE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview, Historic and Forecast Data
    • 8.3.2. North America By Segment
    • 8.3.3. North America By Country
    • 8.3.4. United State
    • 8.3.5. Canada
    • 8.3.6. Mexico
  • 8.4. Europe
    • 8.4.1. Overview, Historic and Forecast Data
    • 8.4.2. Europe by Segment
    • 8.4.3. Europe by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7. Italy
    • 8.4.8. Russia
    • 8.4.9. Rest Of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview, Historic and Forecast Data
    • 8.5.2. Asia Pacific by Segment
    • 8.5.3. Asia Pacific by Country
    • 8.5.4. China
    • 8.5.5. India
    • 8.5.6. Japan
    • 8.5.7. South Korea
    • 8.5.8. Australia
    • 8.5.9. Rest Of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview, Historic and Forecast Data
    • 8.6.2. Latin America by Segment
    • 8.6.3. Latin America by Country
    • 8.6.4. Brazil
    • 8.6.5. Argentina
    • 8.6.6. Peru
    • 8.6.7. Chile
    • 8.6.8. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview, Historic and Forecast Data
    • 8.7.2. Middle East & Africa by Segment
    • 8.7.3. Middle East & Africa by Country
    • 8.7.4. Saudi Arabia
    • 8.7.5. UAE
    • 8.7.6. Israel
    • 8.7.7. South Africa
    • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE BIOINFORMATICS SERVICE COMPANIES

  • 9.1. Bioinformatics Service Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF BIOINFORMATICS SERVICE INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Illumina
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Thermo Fisher Scientific
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Strand Life Sciences
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. CD Genomics
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Biomax Informatics
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. DNANEXUS
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Agilent Technologies
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. QIAGEN
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Gene Codes
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. BGI Group
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Gene Code
    • 10.13.1. Company Overview
    • 10.13.2. Financials
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. PerkinElmer
    • 10.14.1. Company Overview
    • 10.14.2. Financials
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. Premier Biosoft
    • 10.15.1. Company Overview
    • 10.15.2. Financials
    • 10.15.3. Products
    • 10.15.4. Recent Developments
  • 10.16. Biomatters Geneious
    • 10.16.1. Company Overview
    • 10.16.2. Financials
    • 10.16.3. Products
    • 10.16.4. Recent Developments
  • 10.17. Creative-Biolabs
    • 10.17.1. Company Overview
    • 10.17.2. Financials
    • 10.17.3. Products
    • 10.17.4. Recent Developments
  • 10.18. DNASTAR
    • 10.18.1. Company Overview
    • 10.18.2. Financials
    • 10.18.3. Products
    • 10.18.4. Recent Developments
  • 10.19. GSL Biotech LLC (SnapGene)
    • 10.19.1. Company Overview
    • 10.19.2. Financials
    • 10.19.3. Products
    • 10.19.4. Recent Developments
  • 10.20. FIOS Genomics
    • 10.20.1. Company Overview
    • 10.20.2. Financials
    • 10.20.3. Products
    • 10.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product Type (USD MN)
  • Drug Development Market by Geography (USD MN)
  • Gene Therapy Market by Geography (USD MN)
  • Molecular Medicine Market by Geography (USD MN)
  • Veterinary Science Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by End Users (USD MN)
  • Academics and Research Centers Market by Geography (USD MN)
  • Pharmaceutical and Biotechnology Industries Market by Geography (USD MN)
  • Forensics Laboratories Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Bioinformatics Service Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Bioinformatics Service Report
  • Market Research Process
  • Market Research Methodology
  • Global Bioinformatics Service Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by End Users
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Drug Development Market by Geography (USD MN)
  • Gene Therapy Market by Geography (USD MN)
  • Molecular Medicine Market by Geography (USD MN)
  • Veterinary Science Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by End Users (USD MN)
  • Academics and Research Centers Market by Geography (USD MN)
  • Pharmaceutical and Biotechnology Industries Market by Geography (USD MN)
  • Forensics Laboratories Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.